Our team recently spoke to Chemicals Knowledge Hub to discuss the importance of exploiting green chemistry to produce perfect for purpose process chemistry solutions.
Categories
Tags
Analytical Chemistry
Analytical Science
Artificial Intelligence (AI)
Biocatalysis
Catalysis
CatSci Paper
CatSci Patent
Chemical Development
Design of Experiments
Digital
Drug Development
Experimental Design
Green Chemistry
Industry insights
Innovation
Machine Learning (ML)
Material Science
Medium Throughput Experimentation
Oligonucleotides
Principal Component Analysis
Process R&D
QbD
Route Scouting and Selection
Scale-up
Scavenging
Solvents
Sustainability
Technology transfer
Work-up
Our Chief Commercial Officer, Dr Simon Tyler participated in the latest Chemistry Today panel discussion on custom synthesis and manufacturing.
Our Business Development Manager, Dr Joao Madeira do O recently spoke to CHEManager International to discuss the current market for process research and development CROs like CatSci.
In C&EN, our CCO Dr Simon Tyler discusses the importance of welcoming graduate chemists into our company and how we are dedicated to growing our team with bright, talented minds.
How can you ensure success when working with a CRO, such as CatSci, for process research and development? Hear from our CCO, Dr Simon Tyler, in The Medicine Maker.
Earlier this year, CatSci’s team spoke with Pharmaceutical Technology to discuss what makes our novel biocatalytic manufacturing process unique.
CatSci’s Dr Ross Burn joins several other top industry experts to offer insight into what current market developments are most challenging for Pharma CDMOs and how they can tackle them.
Our CEO Dr Ross Burn talks to Michael Ravenscroft about the current trends in CRO outsourcing for the pharmaceutical market.
Learn about our growth as a contract research organisation for the Pharma industry in this article, featuring our CCO, Dr Simon Tyler.
In 2018, our CEO Dr Ross Burn took part in Chemistry Today’s Panel Discussion on Custom Synthesis and Contract Manufacturing.
Dr Ross Burn, CEO and Dr Simon Tyler, CCO at CatSci explain how process optimization can play an integral part in optimizing yield while reducing time and costs.
In a world that is racing ahead with new technologies, has the drug development process distanced itself from the patients it ultimately provides for? Hear more from our Chief Executive Officer, Dr Ross Burn.